Gamma-PNA miniprobes for fluorescent labeling

US9926592B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9926592-B2
Application numberUS-201214357874-A
CountryUS
Kind codeB2
Filing dateNov 14, 2012
Priority dateNov 14, 2011
Publication dateMar 27, 2018
Grant dateMar 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A category of γPNA miniprobes and chimeric γPNA probes is especially useful for detecting RNA and telomeric DNA in a cell sample. In particular, the probes can be used to deliver fluorescent dyes to the telomeres, allowing direct visualization of telomeres in cells.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit for detecting a telomeric DNA in a cell sample, comprising (A) a receptacle that contains a mini-PEG modified γPNA miniprobe that hybridizes with the telomeric DNA, and (B) a receptacle that contains a diluent suitable for hybridization, wherein the mini-PEG modified γPNA miniprobe comprises at least one PNA monomer that is a mini-PEG modified γPNA monomer having the structure wherein Base is a nucleobase. 2. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe consists of six, nine or twelve PNA monomers. 3. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe comprises at least one fluorescent dye as a detectable label. 4. The kit according to claim 3 , wherein the fluorescent dye is selected from the group consisting of Cy3, Cy3B, Cy3.5, Cy5, Cy5.5, Cy7, coumarin, acridine derivatives, eosin derivatives and fluorescein. 5. The kit according to claim 3 , wherein the detectable label is attached to a N-terminal or a C-terminal PNA monomer or a N-terminal or a C-terminal γPNA monomer of the mini-PEG modified γPNA miniprobe. 6. The kit according to claim 3 , wherein the detectable label is attached to an internal PNA monomer or an internal γPNA monomer of the mini-PEG modified γPNA miniprobe. 7. The kit according to claim 3 , wherein the detectable label is attached to a uracil or a cytosine nucleobase of a PNA monomer. 8. The kit according to claim 6 , wherein the detectable label is attached to a γ-carbon of the γPNA monomer. 9. The kit according to claim 8 , wherein the detectable label is attached to the γ-carbon of the γPNA monomer via a linker CH 2 —(O—CH 2 —CH 2 ) n —X, wherein X is selected from the group consisting of —NH 2 —, —CH═CH—, —COOH and —N 3 and n is an integer from 1 to 10. 10. The kit according to claim 1 , wherein the mini-PEG modified γPNA miniprobe comprises two fluorescent dyes. 11. The kit according to claim 1 , wherein the nucleobase sequence of the mini-PEG modified γPNA miniprobe consists of: (A) CCCTAA (nucleobases 13-18 of SEQ ID NO: 2), wherein at least one C is replaced with a G-clamp nucleobase; (B) CCCTAACCC (nucleobases 10-18 of SEQ ID NO: 2); or (C) CCCTAACCCTAA (nucleobases 7-18 of SEQ ID NO: 2). 12. A chimeric mini-PEG modified γPNA miniprobe, comprising: (i) at least one PNA monomer that is a mini-PEG modified γPNA monomer having the structure wherein Base is a nucleobase; (ii) a first, right-handed, domain comprising right-handed PNA monomers, and (iii) a second, left-handed, domain comprising left-handed PNA monomers, wherein the first and second domains are attached to each other end-to-end, optionally via a linker. 13. The chimeric mini-PEG modified γPNA miniprobe according to claim 12 , wherein (A) the first domain comprises from 4 to 10 right-handed PNA monomers; and (B) the second domain comprises from 4 to 7 left handed PNA monomers. 14. The chimeric mini-PEG modified γPNA miniprobe according to claim 12 , wherein the sequence of the first domain is complementary to a telomeric DNA and the second domain does not hybridize with the telomeric DNA. 15. The chimeric mini-PEG modified γPNA miniprobe according to claim 14 , wherein the first domain comprises nine right-handed γPNA monomers and the second domain comprises six left-handed γPNA monomers. 16. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , further comprising at least one detectable label covalently attached to the first domain or the second domain. 17. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , wherein the first domain is attached to the second domain via a linker. 18. The chimeric mini-PEG modified γPNA miniprobe of claim 12 , further comprising at least one detectable label covalently attached to the first domain or the second domain, wherein the first domain is attached to the second domain via a linker. 19. A mini-PEG modified γPNA miniprobe comprising at least one PNA monomer that is a mini-PEG modified γPNA monomer having structure: wherein Base is a nucleobase; wherein the nucleobase sequence of the miniprobe consists of: (A) CCCTAA (nucleobases 18-13 of SEQ ID NO: 2), wherein at least one C is replaced with a G-clamp nucleobase; (B) CCCTAACCC (nucleobases 18-10 of SEQ ID NO: 2); or (C) CCCTAACCCTAA (nucleobases 7-18 of SEQ ID NO: 2). 20. The γPNA miniprobe according to claim 19 , wherein the miniprobe comprises at least one detectable label. 21. The γPNA miniprobe according to claim 19 , comprising two or more of said mini-PEG modified γPNA monomers. 22. The γPNA miniprobe according to claim 19 , wherein all PNA monomers of the miniprobe are said mini-PEG modified γPNA monomers. 23. The γ-RNA miniprobe according to claim 19 , wherein at least one mini-PEG modified γPNA monomer comprises a fluorophore.

Assignees

Inventors

Classifications

  • Peptide nucleic acid, PNA · CPC title

  • C12Q1/6825Primary

    Nucleic acid detection involving sensors · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • incorporating a peptide nucleic acid · CPC title

  • G01N33/533Primary

    with fluorescent label · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9926592B2 cover?
A category of γPNA miniprobes and chimeric γPNA probes is especially useful for detecting RNA and telomeric DNA in a cell sample. In particular, the probes can be used to deliver fluorescent dyes to the telomeres, allowing direct visualization of telomeres in cells.
Who is the assignee on this patent?
Univ Carnegie Mellon, Univ Of Pittsburgh—Of The Commonwealth System Of Higher Education
What technology area does this patent fall under?
Primary CPC classification C12Q1/6825. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).